ARTH

Arch Therapeutics (QB) Stock Price

0.157
-0.006 (-3.68%)
0.157
Best deals to access real time data!
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
$67.09
Canna Trader Pro
Monthly Subscription
for only
$59.99
Small Cap Basic
Monthly Subscription
for only
$33.03
VAT not included
Company Name Stock Ticker Symbol Market Type
Arch Therapeutics Inc (QB) ARTH OTCMarkets Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.006 -3.68% 0.157 16:33:03
Open Price Low Price High Price Close Price Prev Close
0.163 0.15 0.163 0.157 0.163
Bid Price Ask Price Spread News
0.1413 0.166 0.0247 1 -
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
58 238,322 $ 0.156592 $ 37,319 - 0.1225 - 0.26
Last Trade Time Type Quantity Stock Price Currency
15:24:42 8,000 $ 0.157 USD

Arch Therapeutics (QB) Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 30.31M 193.04M - $ - $ - - -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
343.26k $ - 0.00% - -

more financials information »

Arch Therapeutics (QB) News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical ARTH Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.1950.200.150.1718381362,978-0.038-19.49%
1 Month0.1420.20340.130.1625507488,7660.01510.56%
3 Months0.158050.20340.12250.1608485319,984-0.00105-0.66%
6 Months0.1560.2270.12250.1682314325,4470.0010.64%
1 Year0.220.260.12250.1819808313,080-0.063-28.64%
3 Years0.410.690.1210.2806669305,758-0.253-61.71%
5 Years0.4050.9450.1210.445718383,370-0.248-61.23%

Arch Therapeutics (QB) Description

Arch Therapeutics, Inc. is a biotechnology company developing a novel approach to stop bleeding (hemostasis), control leaking (sealant) and manage wounds during surgery, trauma and interventional care. Arch is developing products based on an innovative self-assembling barrier technology platform with the goal of making care faster and safer for patients. Arch's products authorized for commercial marketing are AC5 Advanced Wound System and AC5 Topical Hemostat. Arch's development stage product candidates include AC5-GTM and AC5 Surgical Hemostat, among others.


Your Recent History
USOTC
ARTH
Arch Thera..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.